Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Andy Göbel1, Martina Rauner1, Lorenz C Hofbauer2
1Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Technische Universität Dresden, Germany; German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract:
Cancer is a multifaceted global disease. Transformation of a normal to a malignant cell takes several steps, including somatic mutations, epigenetic alterations, metabolic reprogramming and loss of cell growth control. Recently, the mevalonate pathway has emerged as a crucial regulator of tumor biology and a potential therapeutic target. This pathway controls cholesterol production and posttranslational modifications of Rho-GTPases, both of which are linked to several key steps of tumor progression. Inhibitors of the mevalonate pathway induce pleiotropic antitumor-effects in several human malignancies, identifying the pathway as an attractive candidate for novel therapies. In this review, we will provide an overview about the role and regulation of the mevalonate pathway in certain aspects of cancer initiation and progression and its potential for therapeutic intervention in oncology.
Insights
The mevalonate pathway regulates tumor growth and progression. Inhibiting this pathway shows promise for novel cancer therapies by inducing antitumor effects.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer involves complex cellular changes like mutations and metabolic reprogramming.
- The mevalonate pathway is increasingly recognized for its role in tumor biology.
- This pathway influences cholesterol production and Rho-GTPase activity, critical for cancer progression.
Purpose of the Study:
- To review the role and regulation of the mevalonate pathway in cancer initiation and progression.
- To explore the therapeutic potential of targeting the mevalonate pathway in oncology.
Main Methods:
- Literature review of studies on the mevalonate pathway in cancer.
- Analysis of the pathway's regulation and its impact on tumor development.
- Evaluation of preclinical and clinical data on mevalonate pathway inhibitors.
Main Results:
- The mevalonate pathway is implicated in key cancer hallmarks.
- Inhibitors of this pathway demonstrate broad antitumor activities across various human cancers.
- Targeting the mevalonate pathway offers a promising strategy for cancer treatment.
Conclusions:
- The mevalonate pathway is a significant regulator of cancer biology.
- Its inhibition presents a viable therapeutic avenue for diverse malignancies.
- Further research into mevalonate pathway targeting could lead to novel oncology treatments.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Intrinsic Apoptotic Pathway
Mechanisms of Retrovirus-induced Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

